Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

NOL10 Inhibitors

NOL10, also known as Nucleolar Protein 10, is a protein involved in ribosome biogenesis and nucleolar processing. It plays a crucial role in the maturation of the 18S ribosomal RNA (rRNA), a component of the small ribosomal subunit. Within the nucleolus, NOL10 participates in the early stages of ribosome assembly, where it associates with pre-ribosomal RNA (pre-rRNA) transcripts and facilitates their processing into mature 18S rRNA. This process is essential for the production of functional ribosomes, which are responsible for protein synthesis in the cell. Additionally, NOL10 is involved in the regulation of nucleolar dynamics and the organization of nucleolar components, contributing to the maintenance of nucleolar integrity and function. Inhibition of NOL10 can disrupt ribosome biogenesis and impair protein synthesis, leading to cellular dysfunction and potentially contributing to disease pathology. One possible mechanism of inhibition involves interfering with the interaction between NOL10 and pre-rRNA transcripts, preventing the proper processing and maturation of 18S rRNA. This disruption in ribosome assembly can result in the accumulation of immature ribosomal subunits and the dysregulation of protein synthesis. Additionally, inhibition of NOL10 may disrupt nucleolar organization and dynamics, further compromising ribosome biogenesis and cellular homeostasis. Overall, elucidating the mechanisms of NOL10 inhibition is critical for understanding its role in ribosome biogenesis and its potential implications in cellular processes and disease states.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA and inhibits RNA synthesis, which can directly affect the nucleolar processes, including the maturation of SSU-rRNA. This can indirectly disrupt the function of NOL10.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

This cyclic peptide is a potent inhibitor of RNA polymerase II, reducing mRNA synthesis. By limiting RNA production, NOL10's binding activity can be indirectly hampered.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

DRB selectively inhibits RNA polymerase II, which can indirectly influence the RNA binding activity of NOL10.

Oxaliplatin

61825-94-3sc-202270
sc-202270A
5 mg
25 mg
$112.00
$394.00
8
(1)

A platinum-based chemotherapy drug that causes DNA crosslinking and ultimately inhibits DNA synthesis. It can potentially disrupt nucleolar functions and indirectly affect NOL10.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$107.00
$416.00
$1248.00
35
(2)

This compound inhibits nuclear export by binding to the nuclear export receptor CRM1. It can influence the nucleolar protein dynamics and potentially NOL10's activity.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$69.00
$266.00
8
(1)

An inhibitor of inosine monophosphate dehydrogenase, which results in decreased RNA synthesis. This can indirectly modulate NOL10's RNA binding activity.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

An adenosine analogue that interrupts RNA synthesis upon incorporation. This can impact NOL10's associated rRNA maturation processes.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

This topoisomerase I inhibitor prevents DNA uncoiling, affecting RNA transcription and potentially NOL10's RNA binding activity.

BMH-21

896705-16-1sc-507460
10 mg
$165.00
(0)

A molecule targeting RNA polymerase I and causing its degradation, BMH-21 can influence rRNA maturation and thereby potentially affect NOL10.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

A selective binder of GC-rich DNA sequences, it can impede transcription factors, indirectly affecting RNA binding proteins like NOL10.